Company Filing History:
1 out of 1,289 
1 out of 13 Years Active: 2019
Title: Guillermo Barreto: Innovator in Cancer Diagnosis and Therapy
Introduction
Guillermo Barreto is a notable inventor based in Karben, Germany. He has made significant contributions to the field of cancer research, particularly in the diagnosis and therapy of lung cancer. His innovative work has led to the development of a patented method that could enhance cancer detection and treatment.
Latest Patents
Guillermo Barreto holds a patent for "Isoforms of GATA6 and NKX2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapy." This invention relates to a method for assessing whether a subject suffers from cancer or is prone to it, specifically lung cancer. The method involves measuring the amounts of specific isoforms of GATA6 and/or NKX2-1 in a sample from the subject. Additionally, the invention includes a composition for medical use that comprises inhibitors of these isoforms, as well as a kit designed for assessing cancer susceptibility.
Career Highlights
Throughout his career, Guillermo Barreto has worked with esteemed organizations such as the Max Planck Society for the Advancement of Science and Justus Liebig University Giessen. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Guillermo has collaborated with notable colleagues, including Aditi Mehta and Indrabahadur Singh. These partnerships have further enriched his research and innovation efforts in cancer diagnostics and therapy.
Conclusion
Guillermo Barreto's work exemplifies the intersection of innovation and medical science, particularly in the fight against cancer. His patented methods and compositions hold promise for improving cancer diagnosis and treatment, showcasing the vital role of inventors in advancing healthcare.